Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,022	4,342	5,044	5,333	-	-
Market Cap Growth	25.48%	-13.91%	-5.42%	-	-	-
Enterprise Value	4,109	3,260	3,905	3,860	-	-
Last Close Price	58.29	48.17	52.79	55.15	-	-
PE Ratio	33.31	36.98	46.03	36.53	-	-
Forward PE	33.03	31.74	22.50	30.12	-	-
PS Ratio	3.96	3.94	4.62	6.40	-	-
PB Ratio	2.51	2.14	2.41	2.57	-	-
P/TBV Ratio	2.51	2.15	2.42	2.57	-	-
P/FCF Ratio	127.29	62.06	-	-	-	-
P/OCF Ratio	75.52	27.43	-	178.53	-	-
EV/Sales Ratio	3.24	2.96	3.58	4.63	-	-
EV/EBITDA Ratio	19.54	26.38	35.88	25.71	-	-
EV/EBIT Ratio	22.71	28.92	39.33	26.74	-	-
EV/FCF Ratio	104.15	46.59	-	-	-	-
Debt / Equity Ratio	0.12	0.04	0.03	0.02	0.04	0.05
Debt / EBITDA Ratio	1.12	0.58	0.45	0.25	0.23	0.22
Debt / FCF Ratio	5.99	1.18	-	-	-	-
Net Debt / Equity Ratio	-0.46	-0.54	-0.58	-0.71	-0.26	-0.32
Net Debt / EBITDA Ratio	-4.74	-8.89	-11.18	-9.78	-1.49	-1.50
Net Debt / FCF Ratio	-23.14	-15.70	10.27	172.02	1.76	3.45
Asset Turnover	0.52	0.46	0.46	0.51	0.86	1.01
Inventory Turnover	0.91	0.93	1.10	0.94	0.91	1.07
Quick Ratio	2.74	4.12	5.54	6.84	1.31	1.59
Current Ratio	4.56	6.39	8.22	9.01	3.28	3.19
Return on Equity (ROE)	7.66%	5.71%	5.21%	10.79%	19.65%	23.58%
Return on Assets (ROA)	4.60%	2.92%	2.60%	5.53%	9.51%	12.30%
Return on Invested Capital (ROIC)	12.88%	9.93%	11.55%	22.92%	25.82%	35.11%
Return on Capital Employed (ROCE)	8.90%	5.40%	4.60%	6.80%	16.40%	20.90%
Earnings Yield	3.05%	2.70%	2.17%	2.74%	-	-
FCF Yield	0.79%	1.61%	-2.35%	-0.16%	-	-
Dividend Yield	1.56%	1.87%	1.70%	1.99%	-	-
Payout Ratio	51.65%	68.03%	91.29%	0.06%	0.19%	42.22%
Buyback Yield / Dilution	2.03%	1.76%	-22.83%	-10.09%	-8.03%	-610.24%
Total Shareholder Return	3.56%	3.63%	-21.13%	-8.10%	-8.03%	-610.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.